American Journal of Psychiatry · 1988 · 101 citations · 7 references
MedicinePharmacologyPsychiatryClinical PharmacologyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant PharmacotherapyAntidepressant TherapyDepression ManagementDepression PharmacotherapyAntidepressant EfficacyAntidepressant MedicationsAntidepressant ResponseDouble-blind TrialsMajor DepressionS-adenosylmethionine MetabolismS-adenosylmethionine Supply
The antidepressant properties of S-adenosylmethionine, an endogenous methyl donor, were studied in inpatients who met the DSM-III criteria for major depression. Nine patients given intravenous S-adenosylmethionine and nine given low oral doses of imipramine were compared in a double-blind design for 14 days. The S-adenosylmethionine produced superior results by the end of the first week of treatment. By the end of the second week, 66% of the S-adenosylmethionine patients had a clinically significant improvement in depressive symptoms, compared to 22% of the imipramine patients. Side effects appeared to be fewer with S-adenosylmethionine than with imipramine during the last 5 days of the study.
7
On Methods in the Analysis of Profile Data
Samuel W. Greenhouse, Seymour Geisser · Psychometrika · 1959 · 5K citations
Effect of S-Adenosyl-L-Methionine (SAMe) upon depressive symptoms
A. Agnoli, V.M. Andreoli, M Casacchia et al. · Journal of Psychiatric Research · 1976 · 112 citations
Medicine, Psychiatry, Psychology +10
Open trial of S-adenosylmethionine for treatment of depression
Joseph F. Lipinski, B M Cohen, Frances R. Frankenburg et al. · American Journal of Psychiatry · 1984 · 83 citations
Pharmacy, Pharmacology, Psychiatry +10
Affective Illness and S-Adenosyl Methionine
M. W. P. Carney, James Edeh, Teodoro Bottiglieri et al. · Clinical Neuropharmacology · 1986 · 44 citations
Medicine, Pharmacology, Psychiatry +15